Tubson-2 decoction ameliorates rheumatoid arthritis complicated with osteoporosis in CIA rats involving isochlorogenic acid A regulating IL-17/MAPK pathway
Phytomedicine · 2023-07 · 116 · 154875
DOI: 10.1016/j.phymed.2023.154875 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2023-07. Verfasst von Ya-Jun Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Guangdong Key Laboratory for Research and Development of Natural Drugs, the affiliated hospital, Department of Physiology…. Hauptthemen laut MEDLINE: Arthritis, Experimental, Arthritis, Rheumatoid, Osteoporosis. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Osteoporosis (OP) is considered as one of the major comorbidities of rheumatoid arthritis (RA), and is responsible for fragility fracture. However, there is currently no effective treatment for RA complicated with OP. Tubson-2 decoction (TBD), a Mongolian medicine also known as Erwei Duzhong Decoction, has been shown to exert a preventive effect on post-menopausal osteoporosis (PMOP). The preventive effects of TBD on RA-induced OP, as well as the bioactive compound responsible and the underlying mechanisms, remain to be elucidated. OBJECTIVE: To explore the effects of TBD on RA-induced OP in vivo, and to elucidate the mechanism of isochlorogenic acid A (ICA), the effective component of TBD, in vitro. METHODS: To evaluate the anti-arthritic and anti-osteoporotic effects of TBD, we conducted H&E straining and safranine O/fast green, TEM, immunohistochemistry (IHC), bone histomorphometry, micro-CT imaging, and biomechanical testing in collagen induced arthritis (CIA) rats. The active ingredient in TBD was identified using network pharmacology and molecular docking. The identification was supported by in vivo IHC assay, and further confirmed using qRT-PCR, Western blot, and SEM analysis in TNF-α-treated MH7A cells and/or in LPS-exposed RAW264.7 cells. RESULTS: Oral administration of TBD attenuated the severity of arthritis and osteopenia as well as poor bone quality, in CIA rats. Additionally, TBD and the positive control, tripterygium glycosides (TG), exhibited similar effects in reducing inflammation in both the synovium and ankle joint. They also were both effective in improving bone loss, microarchitecture, and overall bone quality. TBD reduced the expression of MMP13, IL-17, and p-JNK protein in the synovium of CIA rats. ICA, which was screened, suppressed TNF-α or LPS-triggered inflammatory responses via down-regulating IL-17 signaling, involving in MMP13, IL-1β, IL-23, and IL-17, and the MAPK pathway including p-ERK, p-JNK, and p-P38, both in MH7A cells and in RAW264.7 cells. Furthermore, ICA prevented osteoclasts from differentiating and bone resoprtion in a dose-dependent manner in vitro. CONCLUSION: This study provides the first evidence that TBD exerts intervening effects on RA-induced OP, possibly through the downregulation of the IL-17/MAPK signaling pathway by ICA. The findings of our study provides valuable insights for further research in this area.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Guangdong Key Laboratory for Research and Development of Natural Drugs, the affiliated hospital, Department of Physiology, Guangdong Medical University, Zhanjiang 524023, China. Electronic ad…
- Department of Pharmacology, Guangdong Key Laboratory for Research and Development of Natural Drugs, the affiliated hospital, Department of Physiology, Guangdong Medical University, Zhanjiang 524023, China.
- Research Center for Traditional Chinese Medicine of Lingnan (Southern China), Jinan University, Guangzhou, China.
- Department of Pharmacology, Guangdong Key Laboratory for Research and Development of Natural Drugs, the affiliated hospital, Department of Physiology, Guangdong Medical University, Zhanjiang 524023, China; Department of…
- Department of Traditional Chinese Medicine, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Zitieren
APA
Yang, Y. J., Lu, L. J., Wang, J. J., Ma, S. Y., Xu, B. L., Lin, R., Chen, Q. S., Ma, Z. G., Mo, Y. L., & Wang, D. T. (2023). Tubson-2 decoction ameliorates rheumatoid arthritis complicated with osteoporosis in CIA rats involving isochlorogenic acid A regulating IL-17/MAPK pathway. Phytomedicine, 116, 154875. https://doi.org/10.1016/j.phymed.2023.154875
Vancouver
Yang YJ, Lu LJ, Wang JJ, Ma SY, Xu BL, Lin R, et al. Tubson-2 decoction ameliorates rheumatoid arthritis complicated with osteoporosis in CIA rats involving isochlorogenic acid A regulating IL-17/MAPK pathway. Phytomedicine. 2023;116:154875. doi:10.1016/j.phymed.2023.154875
BibTeX
@article{Yang2023,
author = {Yang, Ya-Jun and Lu, Lu-Jiao and Wang, Jia-Jia and Ma, Shao-Yong and Xu, Bi-Lian and Lin, Rui and Chen, Qiu-Sheng and Ma, Zhi-Guo and Mo, Yu-Lin and Wang, Dong-Tao},
title = {Tubson-2 decoction ameliorates rheumatoid arthritis complicated with osteoporosis in CIA rats involving isochlorogenic acid A regulating IL-17/MAPK pathway},
journal = {Phytomedicine},
year = {2023},
volume = {116},
pages = {154875},
doi = {10.1016/j.phymed.2023.154875}
}
EUVIMED